1Department of Neurosurgery, Division of Pediatrics, University of Alabama, Birmingham.
2Department of Neurosurgery, University of Alabama, Birmingham, Alabama; and.
J Neurosurg Pediatr. 2023 Aug 11;32(5):569-575. doi: 10.3171/2023.5.PEDS22568. Print 2023 Nov 1.
The optimal extent of resection of craniopharyngiomas to minimize the long-term risks of hypothalamic and endocrine dysfunction (obesity and panhypopituitarism) in children remains uncertain. The purpose of this study was to report long-term outcomes of pediatric patients with craniopharyngioma undergoing surgical treatment and to study rates of endocrinological and hypothalamic dysfunction in association with extent of resection.
This retrospective study was performed in a cohort of children who underwent resection for craniopharyngioma at Children's of Alabama between 1990 and 2020. The primary outcome was hypothalamic dysfunction defined as a 0.5 increase in body mass index (BMI) Z-score and as a BMI > 2 SDs with or without psychiatric disturbances. Univariable analysis was performed using ANOVA, Wilcoxon rank-sum test, Pearson's chi-square test, and Fisher's exact test as appropriate. Missing data on the primary outcome were handled via multiple imputations. Relative risks were estimated using a multivariable generalized linear model with a priori variables selected using a modified Poisson regression approach with robust error variance to estimate risk ratios.
The cohort includes 39 patients (24 girls and 15 boys; age range 1 month-16 years) who underwent resection of craniopharyngioma at the authors' center between 1990 and 2020. The preoperative goal of treatment was cyst decompression (CD) in 5, subtotal resection (STR) in 13, and gross-total resection (GTR) in 21 patients. The median long-term follow-up after surgery was 8.11 years (average 8.21, range 0.4-24.33 years). Univariate analysis demonstrated a statistically significant increase in hypothalamic dysfunction in patients undergoing GTR when compared to those undergoing STR or CD at 1 month postoperatively (p = 0.006) and 6-11 months postoperatively (p = 0.010), but with this difference not persisting beyond 1 year. Multivariable analysis showed patients older than 10 years at time of surgery to be the most affected and at highest risk of developing significant hypothalamic dysfunction. There was no significant difference in pituitary or neurological function between the STR/CD and GTR groups at 12-24 months or at most recent follow-up. There was no significant difference in BMI Z-scores between the STR/CD and GTR groups at 6-12 months or at most recent follow-up.
Both STR and GTR of craniopharyngioma were associated with significant endocrinological sequelae after 1 year. These potential complications should be discussed with patients and their families, and postoperative protocols should include early nutritional and endocrinological interventions with endocrinologist consultation.
在儿童中,最大限度地切除颅咽管瘤以最小化下丘脑和内分泌功能障碍(肥胖和全垂体功能减退)的长期风险仍然不确定。本研究的目的是报告接受手术治疗的颅咽管瘤患儿的长期结果,并研究与切除范围相关的内分泌和下丘脑功能障碍的发生率。
本回顾性研究纳入了 1990 年至 2020 年期间在阿拉巴马州儿童医院接受颅咽管瘤切除术的儿童队列。主要结局是下丘脑功能障碍定义为体重指数(BMI)Z 分数增加 0.5,或 BMI > 2 SDs 伴有或不伴有精神障碍。使用方差分析、Wilcoxon 秩和检验、Pearson 卡方检验和 Fisher 确切检验进行单变量分析,适当情况下使用缺失数据的多重插补处理主要结局。使用预先指定变量的修正泊松回归方法选择的多变量广义线性模型估计相对风险,使用具有稳健误差方差的方法估计风险比。
该队列包括 39 名患者(24 名女孩和 15 名男孩;年龄 1 个月至 16 岁),他们在作者所在中心于 1990 年至 2020 年间接受颅咽管瘤切除术。术前治疗目标为囊肿减压(CD)5 例,次全切除术(STR)13 例,大体全切除术(GTR)21 例。术后中位数随访时间为 8.11 年(平均 8.21 年,范围 0.4-24.33 年)。单变量分析显示,与接受 STR 或 CD 的患者相比,GTR 患者术后 1 个月(p = 0.006)和 6-11 个月(p = 0.010)时下丘脑功能障碍的发生率显著增加,但这种差异在 1 年后不再存在。多变量分析显示,手术时年龄大于 10 岁的患者受影响最大,发生显著下丘脑功能障碍的风险最高。在 12-24 个月或最近随访时,STR/CD 和 GTR 组之间的垂体或神经功能无显著差异。在 6-12 个月或最近随访时,STR/CD 和 GTR 组之间的 BMI Z 评分无显著差异。
STR 和 GTR 均与颅咽管瘤 1 年后的显著内分泌后遗症相关。应与患者及其家属讨论这些潜在并发症,并制定术后方案,包括早期营养和内分泌干预以及内分泌专家咨询。